Ascend Capital Partners closed its second fund, Ascend Capital Partners Fund II LP, with $791 million in commitments, surpassing its $700 million target. The fund, focused on growth-oriented healthcare services, was oversubscribed and attracted both existing and new limited partners. Ascend has already deployed capital into Seoul Medical Group and Unison Therapy Services, expanding its platform strategy. The firm’s founders bring deep healthcare expertise, with In Seon Hwang formerly leading Warburg Pincus’s global healthcare practice and Dr. Richard Park founding CityMD.
Soundcore Capital Partners announced the closing of its third fund with $450 million in commitments, exceeding its self‑imposed hard cap. The fund attracted 117 limited partners across 12 countries, with the general partner contributing $25 million, representing just under 6% of...
HGGC announced the close of its fifth flagship vehicle, HGGC Fund V LP, with roughly $3.2 billion in commitments, outpacing its $2.5 billion target and the $2.8 billion hard cap. The capital pool draws from a mix of new and existing public and...
Private equity firm HGGC announced the closing of its fifth flagship fund, HGGC Fund V LP, with approximately $3.2 billion in capital commitments, surpassing its $2.5 billion target and $2.8 billion hard cap. The fund, launched in March 2025, attracted new and existing...
Soundcore Capital Partners announced the close of its third fund, Soundcore Capital Partners Fund III LP, with $450 million in capital commitments, surpassing its hard cap. The fund, backed by over 117 investors across 12 countries and a $25 million...